For adults with Multiple Myeloma who have received at least 2 prior treatments
Going progression free longer means going longer without your Multiple Myeloma getting worse
In a clinical study, SARCLISA given with Pomalyst® (pomalidomide) and dexamethasone (Pd) extended the time people lived without their multiple myeloma getting worse compared to Pd alone (median of 11.5 months vs 6.5 months).